Literature DB >> 25819430

Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs).

Darren J Perkins1, Stefanie N Vogel2.   

Abstract

The Toll like receptors (TLRs) and the type I interferons have critical roles to play in innate immunity. In this review we will discuss new developments relating to the important area of TLR/IFN cross regulation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IFN-β; Interferon; LPS; TLR; TRAF3

Mesh:

Substances:

Year:  2015        PMID: 25819430      PMCID: PMC4475459          DOI: 10.1016/j.cyto.2015.03.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  35 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

3.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.

Authors:  Hans Häcker; Vanessa Redecke; Blagoy Blagoev; Irina Kratchmarova; Li-Chung Hsu; Gang G Wang; Mark P Kamps; Eyal Raz; Hermann Wagner; Georg Häcker; Matthias Mann; Michael Karin
Journal:  Nature       Date:  2005-11-23       Impact factor: 49.962

4.  TRAM is required for TLR2 endosomal signaling to type I IFN induction.

Authors:  Julianne Stack; Sarah L Doyle; Dympna J Connolly; Line S Reinert; Kate M O'Keeffe; Rachel M McLoughlin; Søren R Paludan; Andrew G Bowie
Journal:  J Immunol       Date:  2014-11-10       Impact factor: 5.422

5.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.

Authors:  Nadra J Nilsen; Gregory I Vladimer; Jørgen Stenvik; M Pontus A Orning; Maria V Zeid-Kilani; Marit Bugge; Bjarte Bergstroem; Joseph Conlon; Harald Husebye; Amy G Hise; Katherine A Fitzgerald; Terje Espevik; Egil Lien
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

7.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

8.  Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.

Authors:  Marina A Dobrovolskaia; Andrei E Medvedev; Karen E Thomas; Natalia Cuesta; Vladimir Toshchakov; Tianbo Ren; Michael J Cody; Suzanne M Michalek; Nancy R Rice; Stefanie N Vogel
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.

Authors:  Darren J Perkins; Swamy K Polumuri; Meghan E Pennini; Wendy Lai; Ping Xie; Stefanie N Vogel
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

Review 10.  Molecular mechanisms that influence the macrophage m1-m2 polarization balance.

Authors:  Nan Wang; Hongwei Liang; Ke Zen
Journal:  Front Immunol       Date:  2014-11-28       Impact factor: 7.561

View more
  14 in total

1.  Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.

Authors:  Caio C B Bomfim; Logan Fisher; Eduardo P Amaral; Lara Mittereder; Katelyn McCann; André A S Correa; Sivaranjani Namasivayam; Muthulekha Swamydas; Mahtab Moayeri; Jonathan M Weiss; Raj Chari; Daniel W McVicar; Diego L Costa; Maria R D'Império Lima; Alan Sher
Journal:  Front Cell Infect Microbiol       Date:  2022-05-02       Impact factor: 6.073

2.  The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors.

Authors:  Marie Rouanet; Naima Hanoun; Cindy Ferreira; Pierre Garcin; Martin Sramek; Godefroy Jacquemin; Agnès Coste; Delphine Pagan; Carine Valle; Emeline Sarot; Vera Pancaldi; Frédéric Lopez; Louis Buscail; Pierre Cordelier
Journal:  Mol Ther       Date:  2022-01-14       Impact factor: 12.910

Review 3.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  TRAF3: a novel tumor suppressor gene in macrophages.

Authors:  Almin I Lalani; Chang Luo; Yeming Han; Ping Xie
Journal:  Macrophage (Houst)       Date:  2015-09-30

5.  A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.

Authors:  Kelsey A Gregg; Erin Harberts; Francesca M Gardner; Mark R Pelletier; Corinne Cayatte; Li Yu; Michael P McCarthy; Jason D Marshall; Robert K Ernst
Journal:  Vaccine       Date:  2018-05-31       Impact factor: 3.641

Review 6.  TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.

Authors:  Gail A Bishop; Laura L Stunz; Bruce S Hostager
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

Review 7.  Type I interferons and endoplasmic reticulum stress in health and disease.

Authors:  Jenny Sprooten; Abhishek D Garg
Journal:  Int Rev Cell Mol Biol       Date:  2019-11-19       Impact factor: 6.813

8.  Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth.

Authors:  Shahin Ranjbar; Viraga Haridas; Aya Nambu; Luke D Jasenosky; Supriya Sadhukhan; Thomas S Ebert; Veit Hornung; Gail H Cassell; James V Falvo; Anne E Goldfeld
Journal:  iScience       Date:  2019-11-06

9.  Enhanced Signaling Through the TLR9 Pathway Is Associated With Resistance to HIV-1 Infection in Chinese HIV-1-Exposed Seronegative Individuals.

Authors:  Junjun Jiang; Xi Hu; Wenwei Li; Jie Liu; Bingyu Liang; Hui Chen; Jiegang Huang; Ning Zang; Chuanyi Ning; Yanyan Liao; Rongfeng Chen; Jingzhen Lai; Jiemei Chu; Peijiang Pan; Ping Cui; Qiao Tang; Xiu Chen; Hao Liang; Li Ye
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

10.  TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response.

Authors:  Hellen S Teixeira; Jiawei Zhao; Ethan Kazmierski; Denis F Kinane; Manjunatha R Benakanakere
Journal:  Cells       Date:  2020-08-17       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.